Dynavax Technologies Corporation

GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical s...

GlaxoSmithKline announced today that the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research has released the first lots of FluLaval...

GlaxoSmithKline announced today that the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research has released the first lots of FluLaval...

Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation as a development candidate ...

GlaxoSmithKline today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.

Shionogi-ViiV Healthcare LLC today reported data from two Phase IIb studies showing that its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 (&apo...

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phas...

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration voted to allow Avandia to remain on the market. Committee membe...